Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dosing of Oral Anticancer Drugs in Older Adults With Cancer: a Randomized Pilot Study.

NCT05949424 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05949424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dosing of Oral Anticancer Drugs in Older Adults With Cancer: a Randomized Pilot Study.
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2024
Completion date
March 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, endometrium carcinoma, ovarian carcinoma, renal cell carcinoma, thyroid carcinoma